By Dennis Thompson

It's been overshadowed by the new coronavirus outbreak in China, but this year's flu season could be near its peak after surging throughout the United States for months.

At least 14,000 people have died and 250,000 have already been hospitalized during the 2019-2020 flu season, according to estimates from the U.S. Centers for Disease Control and Prevention. More than 26 million Americans have fallen ill with flu-like symptoms.

"There is a deadly respiratory virus that is circulating throughout the United States, and it is at its peak. It is not novel coronavirus," said Dr. Pritish Tosh, an infectious disease specialist with the Mayo Clinic, in Rochester, Minn.

This flu season has come in two waves and has been particularly hard on children, the experts said.

The season started early, in October, with an unusual wave of influenza B virus.

Influenza B is less likely than other strains to mutate and become more virulent. That means it poses a greater threat to young people than to older folks, who may have gained immunity because they encountered the strain before.

There have been 105 flu-related deaths among children this season, a higher total at this point of the year than any season in the past decade. Two-thirds of these deaths were associated with influenza B viruses, the CDC noted.

More recently, a second wave of influenza A viruses featuring the H1N1 strain has hit the United States, Tosh noted.

"This has been an extended season, and we've certainly been seeing a lot of hospitalizations and bad outcomes from it," Tosh said. "We will likely continue to see high influenza activity for several weeks. We are probably at its peak right now. I sure hope it doesn't get much worse."

With a less effective flu vaccine the season could have been even more severe, experts note. However, lab and epidemiologic data show that this year's flu shot is a pretty good match with the major strains circulating throughout the country.

The H1N1 part of the flu vaccine is essentially a 100% match with the circulating strain, CDC lab data show.

"We've had a lot fewer deaths this year, thankfully, and maybe some of that is because of the match with the H1N1 influenza A portion of the vaccine," said Dr. Kristin Englund, an infectious diseases doctor with the Cleveland Clinic.

Meanwhile, the influenza B part of the vaccine is a 60% match to the circulating strain. That might explain why that flu strain got such an early toehold, said Dr. Bernard Camins, medical director for infection prevention at the Mount Sinai Health System in New York City.

"I am pretty sure the influenza B circulating strain is not a good match with the current vaccine," Camins said. "I think that's probably why there are a lot more cases with influenza B now."

Still, early estimates from the CDC show that the vaccine is 50% effective in preventing influenza B infections. The agency said that indicates the vaccine has "significantly reduced medical visits associated with influenza so far this season," according to a report published Feb. 21 in the CDC publication Morbidity and Mortality Weekly Report.